[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Whitehawk Therapeutics Inc (WHWK)

Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Whitehawk Therapeutics Inc 2 HEADQUARTERS PLAZA EAST BUILDING 11TH FLOOR MORRISTOWN NJ 7960 USA

https://ir.whitehawktx.com Employees: 23 P: 551-321-2234

Sector:

Medical

Description:

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 199,643
Enterprise Value, $K 162,073
Shares Outstanding, K 47,197
Float, K 23,646
% Float 50.10%
Short Interest, K 694
Short Float 1.47%
Days to Cover 3.88
Short Volume Ratio 0.21
% of Insider Shareholders 49.90%
% of Institutional Shareholders 52.08%

Financials:

Annual Sales, $ 7,150 K
Annual Net Income, $ -20,600 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,250 K
EBIT, $ -114,410 K
EBITDA, $ -115,860 K

Growth:

1-Year Return 170.13%
3-Year Return -45.49%
5-Year Return -76.10%
5-Year Revenue Growth -52.33%
5-Year Earnings Growth -16.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 03/12/26
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -1.72
EPS Growth vs. Prev Qtr -30.77%
EPS Growth vs. Prev Year 49.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/27/21

WHWK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.88%
Return-on-Assets % -58.98%
Profit Margin % -288.11%
Debt/Equity 0.00
Price/Sales 27.74
Price/Cash Flow N/A
Price/Book 1.45
Book Value/Share 2.89
Interest Coverage -0.31
60-Month Beta 0.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.